For: | Liu ZX, Chen WJ, Wang Y, Chen BQ, Liu YC, Cheng TC, Luo LL, Chen L, Ju LL, Liu Y, Li M, Feng N, Shao JG, Bian ZL. Interleukin-34 deficiency aggravates development of colitis and colitis-associated cancer in mice. World J Gastroenterol 2022; 28(47): 6752-6768 [PMID: 36620338 DOI: 10.3748/wjg.v28.i47.6752] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i47/6752.htm |
Number | Citing Articles |
1 |
Dzhuliia Dzhalilova, Natalia Zolotova, Nikolai Fokichev, Olga Makarova. Murine models of colorectal cancer: the azoxymethane (AOM)/dextran sulfate sodium (DSS) model of colitis-associated cancer. PeerJ 2023; 11: e16159 doi: 10.7717/peerj.16159
|
2 |
Jiameng Shang, Yuxin Xu, Shengdan Pu, Xiaotong Sun, Xinyuan Gao. Role of IL-34 and its receptors in inflammatory diseases. Cytokine 2023; 171: 156348 doi: 10.1016/j.cyto.2023.156348
|
3 |
Yanan Li, Feng Xu, Yulai Fang, Yuan Cui, Zhenxing Zhu, Yuguang Wu, Yiheng Tong, Jingyi Hu, Lei Zhu, Hong Shen. Inflammation-fibrosis interplay in inflammatory bowel disease: mechanisms, progression, and therapeutic strategies. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1530797
|
4 |
Weijie Chen, Tongtong Zhou, Yicun Liu, Leilei Luo, Yujing Ye, Lixian Wei, Jian Chen, Zhaolian Bian. Genetically engineered bacteria expressing IL-34 alleviate DSS-induced experimental colitis by promoting tight junction protein expression in intestinal mucosal epithelial cells. Molecular Immunology 2025; 178: 64 doi: 10.1016/j.molimm.2025.01.008
|